ALEXANDER D. STOYEN, PH.D.
JON SIENKOWSKI, MBA / BUSINESS ACCELERATION MANAGER
Jon Sienkowski joins Dawnbreaker with 13 years of manufacturing, product development, commercial, and finance experience in the automotive and fuel cell industries.
Mr. Sienkowski began his career in product engineering and manufacturing at General Motors, working at the vehicle proving grounds and a high volume manufacturing plant. Subsequently, he joined GM's Fuel Cell R&D program where he progressed to a position as a Systems Engineer, responsible for development of the hydrogen delivery subsystem. In this role, Mr. Sienkowski gained solid experience in technology selection and requirements development and his work resulted in five patents in control strategies and component innovations. Most recently, Mr. Sienkowski worked on GM's fuel cell commercial development team as a Senior Cost Engineer where he was involved in supplier selection, strategies for technology cost reduction, and forecasting fuel cell technology cost over a 15 year horizon.
Mr. Sienkowski has a Bachelor of Science in Electrical Engineering from Purdue University and received his MBA from the William E. Simon Graduate School of Business Administration at the University of Rochester concentrating in Competitive Strategy, Finance, and Entrepreneurship.
RICHARD SMERBECK / BUSINESS ACCELERATION MANAGER
Richard Smerbeck brings 25 plus years of R&D experience in the pharmaceutical and medical device industries to Dawnbreaker. Over the course of his career, Richard has played key roles in the development and launch of more than 50 new products. These include Rx and OTC pharmaceutical products, contact lens care products, nutritional supplements and, skin care products. Additionally, he is an inventor on 25 patents.
Richard has held a series of increasingly responsible positions at Warner Lambert, Schering Plough and finally at Bausch and Lomb where he retired as Vice President, Global Pharmaceutical Research and Development. In this role, Richard was responsible, at the corporate level, for the development and launch of all new pharmaceutical products. During his tenure at Bausch and Lomb, he has also held the positions of Vice President, Research, Development and Engineering, Europe; Vice President, New Product Commercialization and; Director of Product and Process Development. Additionally, Richard was the principal of RVS Pharmaceutical R&D Consulting providing product development expertise to clients ranging from start-ups to established corporations. Over the course of his career, Richard has worked successfully along the entire product development continuum - from basic/applied research to pre-clinical efficacy methods development, business development; program management, product and process development, to executive management.
Richard has a B.S in Biology from Duquesne University in Pittsburgh, Pennsylvania. He, his wife Meg and their youngest child Kevin reside in Pittsford, NY.
ALEXANDER D. STOYEN, PH.D. / Business Acceleration Manager
Dr. Stoyen joined Dawnbreaker in 2007 to lead the Strategic Initiatives area and to serve on the Business Acceleration team. He has expert knowledge of software technology and product development, business development, funding, marketing and program management, interrelationships among academia, industry and government sectors, and government relations as pertaining to budgeting, planning, authorizations and appropriations. Dr. Stoyen's strong organizational and communications skills accompany the foregoing credentials in the technology field.
Previously, Dr. Stoyen was the Founder, Chairman and Chief Executive Officer of 21st Century Systems Inc. (21CSI®), a pioneer in agent-based decision support systems for time and mission critical Department of Defense and Homeland Security applications. Under Dr. Stoyen's leadership, 21CSI grew to nearly 150 employees. 21CSI's products, such as the High Resolution Situational Awareness system being used by the Marines in Iraq, transformed the way people and computers work together. Use of intelligent agents enabled these systems to adapt to changing environments and improve crucial decisions and response time by continually assessing multiple data streams. In both 2005 and 2006, 21CSI was named to Inc. Magazine's Inc. 500 list of America's fastest growing private companies. 21CSI has been named to the Deloitte's Technology Fast 50 2006 List for Virginia. In 2006, 21CSI was honored by the prestigious 2006 Tibbetts Award, which recognized the company as a leader in small business innovative research (SBIR).
Dr. Stoyen's other prior appointments included the University of Nebraska and the Peter Kiewit Institute of Information Science, Technology and Engineering, the New Jersey Institute of Technology, IBM T. J. Watson Research Center and IBM Zurich Research Laboratory. Dr. Stoyen has contributed significantly to a number of key technological concepts in real-time systems, complex systems and decision support systems. He has published more than 130 articles in journals, books and conference proceedings. Dr. Stoyen has served as an organizer of many professional events, chair of IEEE Technical Committees, and editor or guest editor of book series and archived peer-reviewed journals, including the IEEE Computer, J. Real-Time Imaging and J. Real-Time Systems. Dr. Stoyen is a recipient of an IEEE Computer Society Golden Core Award.
Dr. Stoyen holds a Ph.D. in Computer Science from the University of Toronto.
CAROL VAN BUREN, MS / BUSINESS ACCELERATION MANAGER
Carol Van Buren has been with Dawnbreaker for over 9 years and has worked with over 300 companies helping with transition assistance as a Business Acceleration Manager. At Dawnbreaker, Ms. Van Buren has served as a Portfolio Manager, providing commercialization/transition planning assistance and market research deliverables to over 60 National Science Foundation Phase I and 30 Navy Phase II SBIR/STTR awardees. She has worked with several government agency clients, including Department of Energy, Navy, and NSF, as well as many clients in the private sector.
Prior to joining Dawnbreaker, Ms. Van Buren served as Strategic Marketing Manager for PACS/Digital Medical Imaging Solutions at AGFA’s Healthcare Informatics Division in Waterloo, Canada. Ms. Van Buren has made her mark in the biotech and health care industries, in roles spanning new business development, strategic marketing and sales, product management and medical R&D across companies such as Kodak, MEDSTAT and Preferred Care.
Ms. Van Buren holds a M.S. in Preventive Medicine from the University of Rochester and a B.A. in Biology-Chemistry from Skidmore College. She completed her doctoral training in Clinical & Chronic Disease Epidemiology combined with Health Policy, Finance & Management at the Johns Hopkins University. Her passion and focus is the ever-evolving biotech industry.